These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1982304)

  • 1. A disintegration test for vaginal tablets: comparison with BP test.
    Yamaguchi M; Tanno K; Sugibayashi K; Morimoto Y
    J Pharm Pharmacol; 1990 Nov; 42(11):795-6. PubMed ID: 1982304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design and evaluation of a new disintegration test apparatus for vaginal tablets].
    Yamaguchi M; Tanno K
    Yakugaku Zasshi; 1986 Mar; 106(3):228-32. PubMed ID: 3723347
    [No Abstract]   [Full Text] [Related]  

  • 4. Disintegration test to measure lot-to-lot variations of vaginal tablets.
    Yamaguchi M; Tanno K; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2314-6. PubMed ID: 2279299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
    Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test.
    Harada T; Narazaki R; Nagira S; Ohwaki T; Aoki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1072-5. PubMed ID: 16880646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
    Hoashi Y; Tozuka Y; Takeuchi H
    Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterising the disintegration properties of tablets in opaque media using texture analysis.
    Scheuerle RL; Gerrard SE; Kendall RA; Tuleu C; Slater NK; Mahbubani KT
    Int J Pharm; 2015; 486(1-2):136-43. PubMed ID: 25791759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutics, Drug Delivery and Pharmaceutical Technology: A New Test Unit for Disintegration End-Point Determination of Orodispersible Films.
    Low A; Kok SL; Khong Y; Chan SY; Gokhale R
    J Pharm Sci; 2015 Nov; 104(11):3893-903. PubMed ID: 27524687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
    Desai PM; Liew CV; Heng PW
    Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Test Unit for Disintegration End-Point Determination of Orodispersible Films.
    Low A; Kok SL; Khong YM; Chan SY; Gokhale R
    J Pharm Sci; 2015 Nov; 104(11):3893-903. PubMed ID: 26296236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
    Jung HA; Augsburger LL
    Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market.
    Hebron Y; Tettey JN; Pournamdari M; Watson DG
    J Clin Pharm Ther; 2005 Dec; 30(6):575-81. PubMed ID: 16336290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP dissolution III: semilogarithmic dissolution patterns of tablets in rotating-basket assemblies.
    Carstensen JT; Wright JL; Blessel K; Sheridan J
    J Pharm Sci; 1978 Jul; 67(7):982-4. PubMed ID: 660522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Disintegration Tester for Solid Dosage Forms Enabling Adjustable Hydrodynamics.
    Kindgen S; Rach R; Nawroth T; Abrahamsson B; Langguth P
    J Pharm Sci; 2016 Aug; 105(8):2402-9. PubMed ID: 27422086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of dissolution and disintegration results for an immediate-release tablet.
    Nickerson B; Kong A; Gerst P; Kao S
    J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gasket insert modification of U.S.P. tablet disintegration apparatus.
    KAPLAN LL; KISH JA
    J Pharm Sci; 1962 Jul; 51():706. PubMed ID: 14453757
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of Delonix regia seed gum as a novel tablet binder.
    Adetogun GE; Alebiowu G
    Acta Pol Pharm; 2009; 66(4):433-8. PubMed ID: 19702177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach.
    Rajkumar AD; Reynolds GK; Wilson D; Wren S; Hounslow MJ; Salman AD
    Eur J Pharm Biopharm; 2016 Sep; 106():88-96. PubMed ID: 27287552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation.
    Wang L; Tang X
    Int J Pharm; 2008 Feb; 350(1-2):181-7. PubMed ID: 17920795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.